Manufacture

Delays arising from formulation issues are commonplace in the industry. It’s time to start thinking about the problem earlier.

As novel technologies begin to make inroads into the biopharma industry, we have to consider what will come next and how beneficial it will be.

As a leading partner and supplier to the industry, MilliporeSigma continues to strengthen and enhance its supply chain capabilities.

Meet the grand winner of The Medicine Maker 2018 Innovation Awards: Zydis Ultra!

Viral contamination can have devastating effects. But innovations upstream can help prevent that.

Helping to meet demands and reduce shortages... Is continuous manufacturing the way forward for pharma?

How can we reduce process risk and development times, streamline supply chains, lower costs and improve quality? Standardizing single-use.

Sitting Down With... David Schoneker, Global Regulatory Director, Strategic Relationships at Colorcon.

Could a text message make all the difference in ensuring the integrity of drug products?

The cannabis business is booming as century-old legal conventions restricting use begin to unravel. Can pharma ride the wave?